Exact Mass: 434.2668

Exact Mass Matches: 434.2668

Found 167 metabolites which its exact mass value is equals to given mass value 434.2668, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

(12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C

2,5-dimethyl-8-(propan-2-yl)-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-14,17,21-triol

C25H38O6 (434.2668)


(12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C is found in mushrooms. (12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C is a constituent of Hericium erinaceum (lions mane)

   

Erinacine C

13-(hydroxymethyl)-2,5-dimethyl-8-(propan-2-yl)-15,20,22-trioxapentacyclo[12.8.0.0²,¹⁰.0⁵,⁹.0¹⁶,²¹]docosa-8,12-diene-17,18-diol

C25H38O6 (434.2668)


Erinacine C is found in mushrooms. Erinacine C is a metabolite of Hericium erinaceum (lions mane).

   

MG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (5Z,7S,8E,10Z,13Z,17R,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C25H38O6 (434.2668)


MG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/0:0)

(2S)-2,3-dihydroxypropyl (4Z,7Z,10S,11E,13Z,15E,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoate

C25H38O6 (434.2668)


MG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

1,3-Dihydroxypropan-2-yl (5Z,7R,8E,10Z,13Z,17S,19Z)-7,17-dihydroxydocosa-5,8,10,13,15,19-hexaenoic acid

C25H38O6 (434.2668)


MG(0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

1,3-Dihydroxypropan-2-yl (4Z,7Z,10R,11E,13Z,17S,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid

C25H38O6 (434.2668)


MG(0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

DG(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C25H38O6 (434.2668)


DG(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C25H38O6 (434.2668)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C25H38O6 (434.2668)


DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C25H38O6 (434.2668)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C25H38O6 (434.2668)


DG(2:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C25H38O6 (434.2668)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C25H38O6 (434.2668)


DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C25H38O6 (434.2668)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C25H38O6 (434.2668)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C25H38O6 (434.2668)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0)

C25H38O6 (434.2668)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C25H38O6 (434.2668)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0/0:0)

(2S)-2-(acetyloxy)-3-hydroxypropyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C25H38O6 (434.2668)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C25H38O6 (434.2668)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C25H38O6 (434.2668)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C25H38O6 (434.2668)


DG(2:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C25H38O6 (434.2668)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   
   

Clibadic acid

Clibadic acid

C25H38O6 (434.2668)


   

3beta-Malonyloxy-15-acetoxy-ent-labda-7,13E-dien methylester

3beta-Malonyloxy-15-acetoxy-ent-labda-7,13E-dien methylester

C25H38O6 (434.2668)


   

Iriomoteolide 3a

Iriomoteolide 3a

C25H38O6 (434.2668)


   

Philadelphinone

Philadelphinone

C25H38O6 (434.2668)


   

Vladimuliecin A

Vladimuliecin A

C25H38O6 (434.2668)


   

12-angeloxy-8-O-angeloylshiromodiol

12-angeloxy-8-O-angeloylshiromodiol

C25H38O6 (434.2668)


   

9,10-diangeloyloxy-11-hydroxy-10,11-dihydrobrickelliol

9,10-diangeloyloxy-11-hydroxy-10,11-dihydrobrickelliol

C25H38O6 (434.2668)


   

Tri-Ac-(3beta,5alpha,16alpha,17alpha)-Androstane-3,16,17-triol

Tri-Ac-(3beta,5alpha,16alpha,17alpha)-Androstane-3,16,17-triol

C25H38O6 (434.2668)


   

15-(3-Hydroxy-2-methylbutanoyl)-(ent-15beta)-9, 15-Dihydroxy-16-kauren-19-oic acid

15-(3-Hydroxy-2-methylbutanoyl)-(ent-15beta)-9, 15-Dihydroxy-16-kauren-19-oic acid

C25H38O6 (434.2668)


   

6alpha,8alpha-dihydroxy-23-carboxy-labd-13(14),17-dien-16,19-olide

6alpha,8alpha-dihydroxy-23-carboxy-labd-13(14),17-dien-16,19-olide

C25H38O6 (434.2668)


   
   

seco-pseudopterosin J

seco-pseudopterosin J

C25H38O6 (434.2668)


   

7-oxo-13alpha-methoxy-8,11,13-abietatriene-18-succinic acid|abiesadine U

7-oxo-13alpha-methoxy-8,11,13-abietatriene-18-succinic acid|abiesadine U

C25H38O6 (434.2668)


   

3,21-Di-Ac-(3alpha,5beta)-3,14,21-Trihydroxypregnan-20-one

3,21-Di-Ac-(3alpha,5beta)-3,14,21-Trihydroxypregnan-20-one

C25H38O6 (434.2668)


   

bakkenolide-O

bakkenolide-O

C25H38O6 (434.2668)


   

3,21-Di-Ac-(3beta,5alpha,17alphaOH)-3,17,21-Trihydroxypregnan-20-one

3,21-Di-Ac-(3beta,5alpha,17alphaOH)-3,17,21-Trihydroxypregnan-20-one

C25H38O6 (434.2668)


   

17-Angeloyl-(ent-12alpha,16alphaOH)-12,16,17-Trihydroxy-19-kauranoic acid|ent-12alpha,16alpha-dihydroxy-17-angeloxykauran-19-oic acid

17-Angeloyl-(ent-12alpha,16alphaOH)-12,16,17-Trihydroxy-19-kauranoic acid|ent-12alpha,16alpha-dihydroxy-17-angeloxykauran-19-oic acid

C25H38O6 (434.2668)


   

8alpha,15(S),23alpha-trihydroxy-23,6alpha-epoxy-labd-13(14),17-dien-16(S),19-olide

8alpha,15(S),23alpha-trihydroxy-23,6alpha-epoxy-labd-13(14),17-dien-16(S),19-olide

C25H38O6 (434.2668)


   

petrosaspongiolide G

petrosaspongiolide G

C25H38O6 (434.2668)


   

Secopseudopterosin A

Secopseudopterosin A

C25H38O6 (434.2668)


   

bakkenolide-Q

bakkenolide-Q

C25H38O6 (434.2668)


   
   

abiesadine V|methyl 7-oxo-13beta-hydroxy-8,11,13-abietatriene-18-succinate

abiesadine V|methyl 7-oxo-13beta-hydroxy-8,11,13-abietatriene-18-succinate

C25H38O6 (434.2668)


   

Tri-Ac-(3beta,5alpha,6alpha,17alpha)-Androstane-3,6,17-triol

Tri-Ac-(3beta,5alpha,6alpha,17alpha)-Androstane-3,6,17-triol

C25H38O6 (434.2668)


   

longipinane-7beta,8alpha,9alpha-triol-1-one 7-angelate-8-methylbutyrate

longipinane-7beta,8alpha,9alpha-triol-1-one 7-angelate-8-methylbutyrate

C25H38O6 (434.2668)


   

6alpha,8alpha,15(S)-trihydroxy-23-oxo-labd-13(14),17-dien-16(S),19-olide

6alpha,8alpha,15(S)-trihydroxy-23-oxo-labd-13(14),17-dien-16(S),19-olide

C25H38O6 (434.2668)


   

9beta-acetoxy-11beta,12beta-epoxy-13alpha-hydroxy-3alpha-propionoxy-1beta,8beta-trinervit-15(17)-ene

9beta-acetoxy-11beta,12beta-epoxy-13alpha-hydroxy-3alpha-propionoxy-1beta,8beta-trinervit-15(17)-ene

C25H38O6 (434.2668)


   

2alpha-Angeloyloxy-3beta-(2-methylbutanoyloxy)isodrimeninol

2alpha-Angeloyloxy-3beta-(2-methylbutanoyloxy)isodrimeninol

C25H38O6 (434.2668)


   

(ent-15beta)-2,3-Dihydroxy-2-methylbutanoyl-15-Hydroxy-16-kauren-19-oic acid|2,3-Dihydroxy-2-methylbutanoyl-15-Hydroxy-16-kauren-19-oic acid

(ent-15beta)-2,3-Dihydroxy-2-methylbutanoyl-15-Hydroxy-16-kauren-19-oic acid|2,3-Dihydroxy-2-methylbutanoyl-15-Hydroxy-16-kauren-19-oic acid

C25H38O6 (434.2668)


   

8-Angeloyl,9-(3-mehtylbutanoyl)-(3beta,8alpha,9beta,10b)-8,9,10-Trihydroxy-5-longipinanone

8-Angeloyl,9-(3-mehtylbutanoyl)-(3beta,8alpha,9beta,10b)-8,9,10-Trihydroxy-5-longipinanone

C25H38O6 (434.2668)


   

11-hydroxy-8,11,13-abietatriene 12-O-beta-D-xylopyranoside

11-hydroxy-8,11,13-abietatriene 12-O-beta-D-xylopyranoside

C25H38O6 (434.2668)


   

[(2R)-2-[(E,2S,4R)-4,6-dimethyloct-6-en-2-yl]-6-oxo-2,3-dihydropyran-3-yl] (2E,4E,6S)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

[(2R)-2-[(E,2S,4R)-4,6-dimethyloct-6-en-2-yl]-6-oxo-2,3-dihydropyran-3-yl] (2E,4E,6S)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H38O6 (434.2668)


   

6-Hydroxysimvastatin

6-Hydroxysimvastatin

C25H38O6 (434.2668)


   

3-Hydroxysimvastatin

3-Hydroxysimvastatin

C25H38O6 (434.2668)


   

6-Hydroxymethylsimvastatin

6-Hydroxymethylsimvastatin

C25H38O6 (434.2668)


   

CJ 14258

2,5-dimethyl-8-(propan-2-yl)-15,19,23-trioxahexacyclo[18.2.1.0^{2,10}.0^{5,9}.0^{13,22}.0^{16,21}]tricos-8-ene-14,17,21-triol

C25H38O6 (434.2668)


   

Apadoline

13-(hydroxymethyl)-2,5-dimethyl-8-(propan-2-yl)-15,20,22-trioxapentacyclo[12.8.0.0^{2,10}.0^{5,9}.0^{16,21}]docosa-8,12-diene-17,18-diol

C25H38O6 (434.2668)


   

13-(Hydroxymethyl)-2,5-dimethyl-8-propan-2-yl-15,20,22-trioxapentacyclo[12.8.0.02,10.05,9.016,21]docosa-8,12-diene-17,18-diol

13-(Hydroxymethyl)-2,5-dimethyl-8-propan-2-yl-15,20,22-trioxapentacyclo[12.8.0.02,10.05,9.016,21]docosa-8,12-diene-17,18-diol

C25H38O6 (434.2668)


   

MG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/0:0)

MG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/0:0)

C25H38O6 (434.2668)


   

MG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/0:0)

MG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/0:0)

C25H38O6 (434.2668)


   

MG(0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

MG(0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C25H38O6 (434.2668)


   

MG(0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

MG(0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C25H38O6 (434.2668)


   

DG(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(2:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C25H38O6 (434.2668)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/2:0/0:0)

C25H38O6 (434.2668)


   

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C25H38O6 (434.2668)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/2:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/2:0)

C25H38O6 (434.2668)


   

DG(2:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(2:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C25H38O6 (434.2668)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/2:0/0:0)

C25H38O6 (434.2668)


   

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C25H38O6 (434.2668)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/2:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/2:0)

C25H38O6 (434.2668)


   

DG(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(2:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C25H38O6 (434.2668)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/2:0/0:0)

C25H38O6 (434.2668)


   

DG(2:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(2:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C25H38O6 (434.2668)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/2:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/2:0)

C25H38O6 (434.2668)


   

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C25H38O6 (434.2668)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/2:0/0:0)

C25H38O6 (434.2668)


   

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C25H38O6 (434.2668)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/2:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/2:0)

C25H38O6 (434.2668)


   

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(2:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C25H38O6 (434.2668)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/2:0/0:0)

C25H38O6 (434.2668)


   

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(2:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C25H38O6 (434.2668)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/2:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/2:0)

C25H38O6 (434.2668)


   

DG(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(2:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C25H38O6 (434.2668)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/2:0/0:0)

C25H38O6 (434.2668)


   

DG(2:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(2:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C25H38O6 (434.2668)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/2:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/2:0)

C25H38O6 (434.2668)


   

Erinacine C

Erinacine C

C25H38O6 (434.2668)


   

(12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C

(12S,15S)-15-O-Demethyl-10,29-dideoxy-11,12-dihydro-striatin C

C25H38O6 (434.2668)


   

TG(22:4)

TG(6:0_6:0_10:4)

C25H38O6 (434.2668)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

ST 19:2;O;Hex

ST 19:2;O;Hex

C25H38O6 (434.2668)


   
   

(2r,3r,4ar,6ar,8s,10r,10ar,10bs)-3-ethenyl-2,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl (2z)-2-methylbut-2-enoate

(2r,3r,4ar,6ar,8s,10r,10ar,10bs)-3-ethenyl-2,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

(2r,3r)-2-[(2s,4r,6e)-4,6-dimethyloct-6-en-2-yl]-6-oxo-2,3-dihydropyran-3-yl (2e,4e,6s)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

(2r,3r)-2-[(2s,4r,6e)-4,6-dimethyloct-6-en-2-yl]-6-oxo-2,3-dihydropyran-3-yl (2e,4e,6s)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H38O6 (434.2668)


   

{5-ethenyl-1,5,7,12,12-pentamethyl-11-[(2-methylbut-2-enoyl)oxy]-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl}acetic acid

{5-ethenyl-1,5,7,12,12-pentamethyl-11-[(2-methylbut-2-enoyl)oxy]-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl}acetic acid

C25H38O6 (434.2668)


   

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2e)-2-methylbut-2-enoate

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2e)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

(1r,5r,10r,16r,18r)-13-(hydroxymethyl)-8-isopropyl-2,5-dimethyl-15,20,22-trioxapentacyclo[12.8.0.0²,¹⁰.0⁵,⁹.0¹⁶,²¹]docosa-8,12-diene-17,18-diol

(1r,5r,10r,16r,18r)-13-(hydroxymethyl)-8-isopropyl-2,5-dimethyl-15,20,22-trioxapentacyclo[12.8.0.0²,¹⁰.0⁵,⁹.0¹⁶,²¹]docosa-8,12-diene-17,18-diol

C25H38O6 (434.2668)


   

7,7a-dimethyl-4-[(3-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

7,7a-dimethyl-4-[(3-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)


   

(2z,6z,10z)-12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylidenepentyl)dodeca-2,6,10-trienoic acid

(2z,6z,10z)-12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylidenepentyl)dodeca-2,6,10-trienoic acid

C25H38O6 (434.2668)


   

(1r,3s,4ar,6ar,8s,10r,10ar,10br)-3-ethenyl-1,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl (2z)-2-methylbut-2-enoate

(1r,3s,4ar,6ar,8s,10r,10ar,10br)-3-ethenyl-1,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

C25H38O6 (434.2668)


   

7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl 2-methylbut-2-enoate

7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

(1s,2r,5r,10r,13s,14s,16s,17r,20s,21r,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-14,17,21-triol

(1s,2r,5r,10r,13s,14s,16s,17r,20s,21r,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-14,17,21-triol

C25H38O6 (434.2668)


   

(1r,5ar,7r,8r,9as,9br)-1-hydroxy-6,6,9a-trimethyl-7-{[(2r)-2-methylbutanoyl]oxy}-1h,3h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-8-yl (2z)-2-methylbut-2-enoate

(1r,5ar,7r,8r,9as,9br)-1-hydroxy-6,6,9a-trimethyl-7-{[(2r)-2-methylbutanoyl]oxy}-1h,3h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-8-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

3-ethenyl-1,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl 2-methylbut-2-enoate

3-ethenyl-1,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

2-(4,6-dimethyloct-6-en-2-yl)-6-oxo-2,3-dihydropyran-3-yl 8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

2-(4,6-dimethyloct-6-en-2-yl)-6-oxo-2,3-dihydropyran-3-yl 8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H38O6 (434.2668)


   

(2s,3s,4r,5r)-2-{[(5r,8s)-2-hydroxy-3,8-dimethyl-5-[(2s)-6-methylhept-5-en-2-yl]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy}oxane-3,4,5-triol

(2s,3s,4r,5r)-2-{[(5r,8s)-2-hydroxy-3,8-dimethyl-5-[(2s)-6-methylhept-5-en-2-yl]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy}oxane-3,4,5-triol

C25H38O6 (434.2668)


   

2-[(1as,2r,2ar,5's,6ar,7s,7as)-7-hydroxy-1a,2a,5',6,6-pentamethyl-3-oxo-tetrahydro-4h-spiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl]ethyl 3-methylbut-2-enoate

2-[(1as,2r,2ar,5's,6ar,7s,7as)-7-hydroxy-1a,2a,5',6,6-pentamethyl-3-oxo-tetrahydro-4h-spiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl]ethyl 3-methylbut-2-enoate

C25H38O6 (434.2668)


   

(1e)-2-[(1s,2s,7s)-2-(4-hydroxy-4-methylpentyl)-5-(hydroxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate

(1e)-2-[(1s,2s,7s)-2-(4-hydroxy-4-methylpentyl)-5-(hydroxymethyl)-2-methyl-6-oxo-7-(2-oxopropyl)cyclohept-4-en-1-yl]ethenyl 3-methylbut-2-enoate

C25H38O6 (434.2668)


   

3-{[(2s,4as,5r,8as)-5-[(3e)-5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl]oxy}-3-oxopropanoic acid

3-{[(2s,4as,5r,8as)-5-[(3e)-5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl]oxy}-3-oxopropanoic acid

C25H38O6 (434.2668)


   

(1r,3r,4r,4as,7s,8s,8as)-7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl (2e)-2-methylbut-2-enoate

(1r,3r,4r,4as,7s,8s,8as)-7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl (2e)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

1-hydroxy-6,6,9a-trimethyl-7-[(2-methylbutanoyl)oxy]-1h,3h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-8-yl 2-methylbut-2-enoate

1-hydroxy-6,6,9a-trimethyl-7-[(2-methylbutanoyl)oxy]-1h,3h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-8-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

3-{[(2s,4ar,5r,8as)-5-[(3e)-5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl]oxy}-3-oxopropanoic acid

3-{[(2s,4ar,5r,8as)-5-[(3e)-5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl]oxy}-3-oxopropanoic acid

C25H38O6 (434.2668)


   

2-[(4-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl)oxy]oxane-3,4,5-triol

2-[(4-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl)oxy]oxane-3,4,5-triol

C25H38O6 (434.2668)


   

8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-16,17,21-triol

8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-16,17,21-triol

C25H38O6 (434.2668)


   

2,10-dihydroxy-2,6,10-trimethyl-3-[(2-methylbut-2-enoyl)oxy]dodeca-6,8,11-trien-4-yl 2-methylbut-2-enoate

2,10-dihydroxy-2,6,10-trimethyl-3-[(2-methylbut-2-enoyl)oxy]dodeca-6,8,11-trien-4-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

3-ethenyl-1,8-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl 2-methylbut-2-enoate

3-ethenyl-1,8-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

4-[(3r,4ar,4bs,6as,7s,10ar,10bs,12as)-1-hydroxy-7-(hydroxymethyl)-4b,7,10a-trimethyl-tetradecahydrophenanthro[2,1-c]pyran-3-yl]-5-hydroxy-5h-furan-2-one

4-[(3r,4ar,4bs,6as,7s,10ar,10bs,12as)-1-hydroxy-7-(hydroxymethyl)-4b,7,10a-trimethyl-tetradecahydrophenanthro[2,1-c]pyran-3-yl]-5-hydroxy-5h-furan-2-one

C25H38O6 (434.2668)


   

7,7a-dimethyl-4-[(2-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

7,7a-dimethyl-4-[(2-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)


   

2-{2-hydroxy-6,10-dimethyl-4-[(2-methylbut-2-enoyl)oxy]-11-oxabicyclo[8.1.0]undec-6-en-3-yl}propyl 2-methylbut-2-enoate

2-{2-hydroxy-6,10-dimethyl-4-[(2-methylbut-2-enoyl)oxy]-11-oxabicyclo[8.1.0]undec-6-en-3-yl}propyl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

methyl (4as,4br,7r,7ar,10ar,11r,12as)-11-(butanoyloxy)-1,1,4a-trimethyl-8-oxo-dodecahydrophenanthro[1,10a-c]furan-7-carboxylate

methyl (4as,4br,7r,7ar,10ar,11r,12as)-11-(butanoyloxy)-1,1,4a-trimethyl-8-oxo-dodecahydrophenanthro[1,10a-c]furan-7-carboxylate

C25H38O6 (434.2668)


   

[(3as,3bs,5as,9as,9br,10s,11as)-10-(acetyloxy)-6,6,9a,11a-tetramethyl-2-oxo-decahydro-3h-phenanthro[2,1-b]furan-3b-yl]methyl acetate

[(3as,3bs,5as,9as,9br,10s,11as)-10-(acetyloxy)-6,6,9a,11a-tetramethyl-2-oxo-decahydro-3h-phenanthro[2,1-b]furan-3b-yl]methyl acetate

C25H38O6 (434.2668)


   

(1s,2r,4r,5s,8r,9s,13r,14s,17s,18s,20s)-2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

(1s,2r,4r,5s,8r,9s,13r,14s,17s,18s,20s)-2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

C25H38O6 (434.2668)


   

(1s,2r,5r,10r,13s,16s,17r,20s,21s,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-16,17,21-triol

(1s,2r,5r,10r,13s,16s,17r,20s,21s,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-16,17,21-triol

C25H38O6 (434.2668)


   

1-[(1s,2r,4as,8ar)-1-(4-methoxy-3-methylidene-4-oxobutyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

1-[(1s,2r,4as,8ar)-1-(4-methoxy-3-methylidene-4-oxobutyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

C25H38O6 (434.2668)


   

6-hydroxy-3,3,7,9-tetramethyl-5-[(2-methylbutanoyl)oxy]-11-oxotricyclo[5.4.0.0²,⁸]undecan-4-yl 2-methylbut-2-enoate

6-hydroxy-3,3,7,9-tetramethyl-5-[(2-methylbutanoyl)oxy]-11-oxotricyclo[5.4.0.0²,⁸]undecan-4-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

methyl (1s,4ar,5s,8ar)-5-[(4s)-4,5-bis(acetyloxy)-3-methylidenepentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

methyl (1s,4ar,5s,8ar)-5-[(4s)-4,5-bis(acetyloxy)-3-methylidenepentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

C25H38O6 (434.2668)


   

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-[(3-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-[(3-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)


   

12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylidenepentyl)dodeca-2,6,10-trienoic acid

12-(acetyloxy)-6-[(acetyloxy)methyl]-10-methyl-2-(4-methyl-3-methylidenepentyl)dodeca-2,6,10-trienoic acid

C25H38O6 (434.2668)


   

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-[(2-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-[(2-methylbutanoyl)oxy]-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)


   

(2s,3r,4s,5r)-2-{[(4bs,8as)-4-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl]oxy}oxane-3,4,5-triol

(2s,3r,4s,5r)-2-{[(4bs,8as)-4-hydroxy-2-isopropyl-4b,8,8-trimethyl-5,6,7,8a,9,10-hexahydrophenanthren-3-yl]oxy}oxane-3,4,5-triol

C25H38O6 (434.2668)


   

[(1s,2s,5s,7s,9s,11s,13r)-5-ethenyl-1,5,7,12,12-pentamethyl-11-{[(2z)-2-methylbut-2-enoyl]oxy}-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl]acetic acid

[(1s,2s,5s,7s,9s,11s,13r)-5-ethenyl-1,5,7,12,12-pentamethyl-11-{[(2z)-2-methylbut-2-enoyl]oxy}-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl]acetic acid

C25H38O6 (434.2668)


   

3-({5-[5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl}oxy)-3-oxopropanoic acid

3-({5-[5-(acetyloxy)-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-2,3,4,5,8,8a-hexahydronaphthalen-2-yl}oxy)-3-oxopropanoic acid

C25H38O6 (434.2668)


   

(1r,2r,5r,10r,14r,16r,17s,18r,21s)-13-(hydroxymethyl)-8-isopropyl-2,5-dimethyl-15,20,22-trioxapentacyclo[12.8.0.0²,¹⁰.0⁵,⁹.0¹⁶,²¹]docosa-8,12-diene-17,18-diol

(1r,2r,5r,10r,14r,16r,17s,18r,21s)-13-(hydroxymethyl)-8-isopropyl-2,5-dimethyl-15,20,22-trioxapentacyclo[12.8.0.0²,¹⁰.0⁵,⁹.0¹⁶,²¹]docosa-8,12-diene-17,18-diol

C25H38O6 (434.2668)


   

(1s,2s,3s,5s,8s,10s,14s)-2-(acetyloxy)-5,10-dihydroxy-8,12,15,15-tetramethyl-4-methylidenetricyclo[9.3.1.0³,⁸]pentadec-11-en-14-yl propanoate

(1s,2s,3s,5s,8s,10s,14s)-2-(acetyloxy)-5,10-dihydroxy-8,12,15,15-tetramethyl-4-methylidenetricyclo[9.3.1.0³,⁸]pentadec-11-en-14-yl propanoate

C25H38O6 (434.2668)


   

(2s,3s,4r,5r)-2-{[(5r,8s)-1-hydroxy-3,8-dimethyl-5-[(2s)-6-methylhept-5-en-2-yl]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}oxane-3,4,5-triol

(2s,3s,4r,5r)-2-{[(5r,8s)-1-hydroxy-3,8-dimethyl-5-[(2s)-6-methylhept-5-en-2-yl]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}oxane-3,4,5-triol

C25H38O6 (434.2668)


   

2-{7-hydroxy-1a,2a,5',6,6-pentamethyl-3-oxo-tetrahydro-4h-spiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl}ethyl 3-methylbut-2-enoate

2-{7-hydroxy-1a,2a,5',6,6-pentamethyl-3-oxo-tetrahydro-4h-spiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl}ethyl 3-methylbut-2-enoate

C25H38O6 (434.2668)


   

(1r,3s,4ar,6ar,8s,10r,10ar,10br)-3-ethenyl-1,8-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl (2z)-2-methylbut-2-enoate

(1r,3s,4ar,6ar,8s,10r,10ar,10br)-3-ethenyl-1,8-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-10-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

3-ethenyl-2,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl 2-methylbut-2-enoate

3-ethenyl-2,10-dihydroxy-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-8-yl 2-methylbut-2-enoate

C25H38O6 (434.2668)


   

methyl 5-[4,5-bis(acetyloxy)-3-methylidenepentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

methyl 5-[4,5-bis(acetyloxy)-3-methylidenepentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

C25H38O6 (434.2668)


   

(1s,2r,4r,5s,9s,13r,17s,18s,20s)-2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

(1s,2r,4r,5s,9s,13r,17s,18s,20s)-2-hydroxy-9-(hydroxymethyl)-5,9,13-trimethyl-19,21,24-trioxahexacyclo[16.5.1.0¹,²⁰.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-22-one

C25H38O6 (434.2668)


   

(1s,4s,5r,9s,10r,12r,13s,14s)-12,14-dihydroxy-5,9-dimethyl-14-({[(2z)-2-methylbut-2-enoyl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

(1s,4s,5r,9s,10r,12r,13s,14s)-12,14-dihydroxy-5,9-dimethyl-14-({[(2z)-2-methylbut-2-enoyl]oxy}methyl)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C25H38O6 (434.2668)


   

(1r)-1-[(1r,2r,5r,7r,8r,10s,11r,14s,15r)-8-(acetyloxy)-10,11-dihydroxy-2,15-dimethylpentacyclo[8.7.0.0²,⁷.0⁵,⁷.0¹¹,¹⁵]heptadecan-14-yl]ethyl acetate

(1r)-1-[(1r,2r,5r,7r,8r,10s,11r,14s,15r)-8-(acetyloxy)-10,11-dihydroxy-2,15-dimethylpentacyclo[8.7.0.0²,⁷.0⁵,⁷.0¹¹,¹⁵]heptadecan-14-yl]ethyl acetate

C25H38O6 (434.2668)


   

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2z)-2-methylbut-2-enoate

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

(1r,3r,3ar)-1,3-dihydroxy-1-isopropyl-3a,6-dimethyl-8-{[(2z)-2-methylbut-2-enoyl]oxy}-2,3,4,7,8,8a-hexahydroazulen-4-yl (2z)-2-methylbut-2-enoate

(1r,3r,3ar)-1,3-dihydroxy-1-isopropyl-3a,6-dimethyl-8-{[(2z)-2-methylbut-2-enoyl]oxy}-2,3,4,7,8,8a-hexahydroazulen-4-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

(1s,2r,5r,10r,14s,16s,17r,20s,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-14,17,21-triol

(1s,2r,5r,10r,14s,16s,17r,20s,22r)-8-isopropyl-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricos-8-ene-14,17,21-triol

C25H38O6 (434.2668)


   

12,14-dihydroxy-5,9-dimethyl-14-{[(2-methylbut-2-enoyl)oxy]methyl}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

12,14-dihydroxy-5,9-dimethyl-14-{[(2-methylbut-2-enoyl)oxy]methyl}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid

C25H38O6 (434.2668)


   

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2z)-2-methylbut-2-enoate

(3r,4s,6e,8e,10s)-2,10-dihydroxy-2,6,10-trimethyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}dodeca-6,8,11-trien-4-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

[(1r,2s,5s,7s,9r,11s,13r)-5-ethenyl-1,5,7,12,12-pentamethyl-11-{[(2z)-2-methylbut-2-enoyl]oxy}-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl]acetic acid

[(1r,2s,5s,7s,9r,11s,13r)-5-ethenyl-1,5,7,12,12-pentamethyl-11-{[(2z)-2-methylbut-2-enoyl]oxy}-6,8-dioxatricyclo[7.4.0.0²,⁷]tridecan-13-yl]acetic acid

C25H38O6 (434.2668)


   

(1r,3r,4r,4as,7s,8s,8as)-7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl (2z)-2-methylbut-2-enoate

(1r,3r,4r,4as,7s,8s,8as)-7,8-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1h-naphthalen-1-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

(1r,2s,4s,5s,6s,7r,8s,9r)-6-hydroxy-3,3,7,9-tetramethyl-5-{[(2r)-2-methylbutanoyl]oxy}-11-oxotricyclo[5.4.0.0²,⁸]undecan-4-yl (2z)-2-methylbut-2-enoate

(1r,2s,4s,5s,6s,7r,8s,9r)-6-hydroxy-3,3,7,9-tetramethyl-5-{[(2r)-2-methylbutanoyl]oxy}-11-oxotricyclo[5.4.0.0²,⁸]undecan-4-yl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

(2s)-2-[(1r,2r,3s,4s,6e,10s)-2-hydroxy-6,10-dimethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-11-oxabicyclo[8.1.0]undec-6-en-3-yl]propyl (2z)-2-methylbut-2-enoate

(2s)-2-[(1r,2r,3s,4s,6e,10s)-2-hydroxy-6,10-dimethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-11-oxabicyclo[8.1.0]undec-6-en-3-yl]propyl (2z)-2-methylbut-2-enoate

C25H38O6 (434.2668)


   

2-{[1-hydroxy-3,8-dimethyl-5-(6-methylhept-5-en-2-yl)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}oxane-3,4,5-triol

2-{[1-hydroxy-3,8-dimethyl-5-(6-methylhept-5-en-2-yl)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}oxane-3,4,5-triol

C25H38O6 (434.2668)


   

1-[1-(4-methoxy-3-methylidene-4-oxobutyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

1-[1-(4-methoxy-3-methylidene-4-oxobutyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

C25H38O6 (434.2668)


   

methyl 11-(butanoyloxy)-1,1,4a-trimethyl-8-oxo-dodecahydrophenanthro[1,10a-c]furan-7-carboxylate

methyl 11-(butanoyloxy)-1,1,4a-trimethyl-8-oxo-dodecahydrophenanthro[1,10a-c]furan-7-carboxylate

C25H38O6 (434.2668)


   

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-{[(2r)-2-methylbutanoyl]oxy}-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-{[(2r)-2-methylbutanoyl]oxy}-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate

C25H38O6 (434.2668)